Cargando…
Current infection control practices used in Australian and New Zealand cystic fibrosis centers
BACKGROUND: The 2013 update of the Infection Prevention and Control (IP&C) Guideline outlined recommendations to prevent the spread of CF respiratory pathogens. We aimed to investigate the current infection control practices used in Australian and New Zealand (NZ) CF centers. METHODS: Two online...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969421/ https://www.ncbi.nlm.nih.gov/pubmed/31952502 http://dx.doi.org/10.1186/s12890-020-1052-y |
_version_ | 1783489325357334528 |
---|---|
author | Stockwell, Rebecca Elizabeth Wood, Michelle ELizabeth Ballard, Emma Moore, Vanessa Wainwright, Claire Elizabeth Bell, Scott Cameron |
author_facet | Stockwell, Rebecca Elizabeth Wood, Michelle ELizabeth Ballard, Emma Moore, Vanessa Wainwright, Claire Elizabeth Bell, Scott Cameron |
author_sort | Stockwell, Rebecca Elizabeth |
collection | PubMed |
description | BACKGROUND: The 2013 update of the Infection Prevention and Control (IP&C) Guideline outlined recommendations to prevent the spread of CF respiratory pathogens. We aimed to investigate the current infection control practices used in Australian and New Zealand (NZ) CF centers. METHODS: Two online surveys were distributed to Australian and NZ CF centers regarding the uptake of selected IP&C recommendations. One survey was distributed to all the Medical Directors and Lead CF Nurses and the second survey was distributed to all the Lead CF Physiotherapists. RESULTS: The response rate was 60% (60/100) for medical/nursing and 58% (14/24) for physiotherapy. Over 90% (55/60) of CF centers followed CF-specific infection control guidelines and consistent infection control practices were seen in most CF centers; 76% (41/54) had implemented segregation strategies for ambulatory care and no CF centers housed people with CF in shared inpatient accommodation. However, the application of contact precautions (wearing gloves and apron/gown) by healthcare professionals when reviewing a CF person was variable between CF center respondents but was most often used when seeing CF persons with MRSA infection in both ambulatory care and hospital admission (20/50, 40% and 42/45, 93% of CF centers, respectively). Mask wearing by people with CF was implemented into 61% (36/59) of centers. Hospital rooms were cleaned daily in 79% (37/47) of CF centers and the ambulatory care consult rooms were always cleaned between consults (49/49, 100%) and at the end of the clinic session (51/51, 100%); however the staff member tasked with cleaning changed with 37% (18/49) of CF centers responding that CF multidisciplinary team (MDT) members cleaned between patients whereas at the end of the clinic session, only 12% (6/51) of the CF MDT cleaned the consult room. CONCLUSIONS: Overall, Australian and NZ CF centers have adopted many recommendations from the IP&C. Although, the application of contact precautions was inconsistent and had overall a low level of adoption in CF centers. In ~ 25% of centers, mixed waiting areas occurred in the ambulatory care. Given the variability of responses, additional work is required to achieve greater consistency between centers. |
format | Online Article Text |
id | pubmed-6969421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69694212020-01-27 Current infection control practices used in Australian and New Zealand cystic fibrosis centers Stockwell, Rebecca Elizabeth Wood, Michelle ELizabeth Ballard, Emma Moore, Vanessa Wainwright, Claire Elizabeth Bell, Scott Cameron BMC Pulm Med Research Article BACKGROUND: The 2013 update of the Infection Prevention and Control (IP&C) Guideline outlined recommendations to prevent the spread of CF respiratory pathogens. We aimed to investigate the current infection control practices used in Australian and New Zealand (NZ) CF centers. METHODS: Two online surveys were distributed to Australian and NZ CF centers regarding the uptake of selected IP&C recommendations. One survey was distributed to all the Medical Directors and Lead CF Nurses and the second survey was distributed to all the Lead CF Physiotherapists. RESULTS: The response rate was 60% (60/100) for medical/nursing and 58% (14/24) for physiotherapy. Over 90% (55/60) of CF centers followed CF-specific infection control guidelines and consistent infection control practices were seen in most CF centers; 76% (41/54) had implemented segregation strategies for ambulatory care and no CF centers housed people with CF in shared inpatient accommodation. However, the application of contact precautions (wearing gloves and apron/gown) by healthcare professionals when reviewing a CF person was variable between CF center respondents but was most often used when seeing CF persons with MRSA infection in both ambulatory care and hospital admission (20/50, 40% and 42/45, 93% of CF centers, respectively). Mask wearing by people with CF was implemented into 61% (36/59) of centers. Hospital rooms were cleaned daily in 79% (37/47) of CF centers and the ambulatory care consult rooms were always cleaned between consults (49/49, 100%) and at the end of the clinic session (51/51, 100%); however the staff member tasked with cleaning changed with 37% (18/49) of CF centers responding that CF multidisciplinary team (MDT) members cleaned between patients whereas at the end of the clinic session, only 12% (6/51) of the CF MDT cleaned the consult room. CONCLUSIONS: Overall, Australian and NZ CF centers have adopted many recommendations from the IP&C. Although, the application of contact precautions was inconsistent and had overall a low level of adoption in CF centers. In ~ 25% of centers, mixed waiting areas occurred in the ambulatory care. Given the variability of responses, additional work is required to achieve greater consistency between centers. BioMed Central 2020-01-17 /pmc/articles/PMC6969421/ /pubmed/31952502 http://dx.doi.org/10.1186/s12890-020-1052-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Stockwell, Rebecca Elizabeth Wood, Michelle ELizabeth Ballard, Emma Moore, Vanessa Wainwright, Claire Elizabeth Bell, Scott Cameron Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title | Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title_full | Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title_fullStr | Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title_full_unstemmed | Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title_short | Current infection control practices used in Australian and New Zealand cystic fibrosis centers |
title_sort | current infection control practices used in australian and new zealand cystic fibrosis centers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969421/ https://www.ncbi.nlm.nih.gov/pubmed/31952502 http://dx.doi.org/10.1186/s12890-020-1052-y |
work_keys_str_mv | AT stockwellrebeccaelizabeth currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters AT woodmichelleelizabeth currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters AT ballardemma currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters AT moorevanessa currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters AT wainwrightclaireelizabeth currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters AT bellscottcameron currentinfectioncontrolpracticesusedinaustralianandnewzealandcysticfibrosiscenters |